NASDAQ:KURA
Kura Oncology, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
kuraoncology.comipo date
Sep 16, 2015
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for th...Show More
Earnings
Earnings Release in 6 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus